This event has now past, please view www.lifescienceevents.com/event-listing for a list of our current events
Talks Included:
-
Effect of oil adjuvants on integrity of foot-and-mouth disease virus vaccine antigens:
Dr. Michiel M. Harmsen, Scientist, Central Veterinary Institute Wageningen UR, Division Virology, Lelystad, The Netherlands
-
Therapuetic use of vaccine for treatment of chronic hepatitis B: from bench to bedside:
Dr. Sheikh Mohamad Fazle Akbar, MBBS, MD, PhD, Principal Investigator, Toshiba General Hospital, Tokyo, Japan
-
Approaches for inducing an immune response against tumor antigens:
Dr Jonathan Lewis, Boston, United States
-
Integration of biology and mathematical modelling towards a better understanding of pathogen behaviour and rational design of improved bacterial vaccines:
Dr Piero Mastroeni, Reader in Infection and Immunity, University of Cambridge, United Kingdom
-
Oncolytic activity of attenuated Measles virus against mesothelioma:
Dr Jean-François FONTENEAU, Chargé de recherche INSERM, INSERM UMR892, CNRS UMR6299, Institut de Recherche en Santé de l’Université de Nantes, France
-
Oral vaccines for the control of poultry diseases:
Professor Anthony Amaechi ATTAMA, Department of Pharmaceutics, University of Nigeria, Nsukka, Nigeria
-
Investigation of antibodies generated in response to vaccination with a HCMV gB subunit vaccine:
Dr Gary R McLean, Imperial College London & London Metropolitan University, London, UK
-
Why do parents who usually vaccinate their children hesitate or refuse General good vs. individual risk:
Dr Anat Gesser-Edelsburg, Head of Health Promotion Department, School of Public Health, University of Haifa, Israel
-
HIV-1 Vaccines: The Yin and Yang of Viral Entry Where We Keep Getting It Wrong:
Dr Cynthia L. Bristow, Chief Executive Officer, Alpha-1 Biologics, New York, USA
-
Plant-derived vaccines:
Dr Athleen Hefferon, University of Toronto, Ont., Canada
-
Patient Safety: Using technology to select the right vaccine, right person, right schedule:
Dr Adrienne Willcox, Health Team Ltd., Glos, UK
-
Russian vaccines against especially dangerous bacterial pathogens:
Dr Valentina A Feodorova, Saratov, Russia
-
Overview of assays for influenza vaccines immunology evaluation and correlates of protection:
Professor Emanuele Montomoli, Dept. of Molecular and Developmental Medicine, University of Siena, Italy
-
Evolutionary Therapy: Immunotherapy As Personalized Medicine:
Dr Ravi A. Madan, Clinical Director, Genitourinary Malignancies Branch, Center for Cancer Research, NCI, NIH, USA
-
Factors Influencing the Recommendation of the Human Papillomavirus Vaccine by South African Doctors:
Dr Muhammad Hoque, University of KwaZulu-Natal (Westville Campus), Durban, South Africa
-
Realising the Potential of Viral Vectored Vaccines:
Dr. Sarah Gilbert, University of Oxford, Jenner Insitute, Oxford, United Kingdom
-
Sublingual vaccination and vaccine delivery systems:
Jaroslav Turánek, Head of Department of Immunology and Immunotherapy, Veterinary Research Institute, Czech Republic
-
State of the art of VLP-based vaccines against influenza virus- commercial and scientific approach:
Dr Beata Gromadzka. Department of Recombinant Vaccines, Intercollegiate Faculty of Biotechnology, University of Gdansk, Medical University of Gdansk, Poland
-
Development of a Lentivirus-Based Reference Material for Zaire Ebola Virus Nucleic Acid Amplification Assays.
Dr. Giada Mattiuzzo, NIBSC, Potters Bar, UK
-
Reference materials and standards for serological assays in vaccine evaluation
Dr Mark Page, NIBSC, Potters Bar, UK
-
Designing new vaccines to safeguard global poliovirus eradication:
Dr Andrew Macadam, NIBSC, Herts, United Kingdom
-
Clostridium difficile Vaccine- C diffense Study:
Dr Amit Arora, Consultant physician and Geriatrician, University Hospital of North Midlands, Stoke on Trent, United Kingdom
-
Aβ immunotherapy with single chain variable fragments for Alzheimer’s disease:
Dr Sandra Villegas, Universitat Autónoma de Barcelona (UAB), Barcelona, Spain
-
New data for Vaccination for Pneumococcus
Assistant Professor Paraskevi A. Katsaounou, Medical School University of Athens, Evangelismos Hospital, Athens, Greece
Contact
Phone:?(+44) 020 3807 3712
Abstract and Poster Presentations
All abstracts accepted for oral presentation are also automatically accepted for poster presentation
INSTRUCTIONS
- How to submit your abstract -www.euroscicon.com/ABSTRACTSUBMISSIONS.pdf
- Accepted poster instructions - ?www.lifescienceevents.com/poster-sessions
- Accepted oral presentation instructions - www.lifescienceevents.com/oral-presentations